on 04 Apr 2023
Last Applicant/ Owned by
2110 Research Row, Suite 610
Dallas
TX
75235
Serial Number
88797771 filed on 14th Feb 2020
Registration Number
7019335 registered on 04th Apr 2023
Correspondent Address
Christopher M. Kindel
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology The mark consists of a DNA triple helix, with one vertical strand being gray, and one vertical strand being orange, and with gray parallel horizontal lines connecting the two strands. Biotechnology research, namely, Read More
Chemicals and biological preparations for use in the biological, biotechnological, medical, and pharmaceutical industries; Medicinal and biological preparations for research, laboratory, and medical laboratory use, namely, preparations used in the manufacture of pharmaceuticals for treating cancer and immunological diseases
28th Nov 2022
28th Nov 2022
Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; Medical research; Research and development of pharmaceutical preparations for the treatment of cancer and immunological diseases; Providing medical and scientific research information in the fields of pharmaceuticals, biologicals, and clinical trials
01st Feb 2020
01st Feb 2020
Pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology
07th Dec 2022
07th Dec 2022
No 88797771
No Service Mark
No IMMU005US
No
No
No
No
No
No
No
No
26.01.29 -
Helixes
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.02 -
Wavy line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
The mark consists of a DNA triple helix, with one vertical strand being gray, and one vertical strand being orange, and with gray parallel horizontal lines connecting the two strands.
| Status Date | Action Taken |
|---|---|
| 04th Apr 2023 | REGISTERED-PRINCIPAL REGISTER |
| 04th Apr 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 28th Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 27th Feb 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 27th Jan 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 26th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 27th Dec 2022 | TEAS STATEMENT OF USE RECEIVED |
| 27th Dec 2022 | USE AMENDMENT FILED |
| 29th Jul 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Jul 2022 | SOU EXTENSION 4 GRANTED |
